The European Commission and German biotech firm CureVac said on Thursday they had concluded a first round of talks this week... Aug 21
CureVac, backed by Microsoft founder and billionaire Bill Gates, listed on the Nasdaq stock market on Friday, raising $213 million.... Aug 17
Berlin is trying to stop Washington from persuading a German company seeking a coronavirus vaccine to move its research to the United States, prompting German ... Mar 16